文献速递产科妇科母胎医学

母亲多囊卵巢综合征或无排卵性不孕与子代精神及轻度神经发育障碍的关联:芬兰人群队列研究

Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.
PubMed 文献 · Hum Reprod · 2020-01-01

芬兰1996-2014年所有活产(n=1 105 997)的人群队列研究,最终纳入1 097 753例出生。母亲PCOS的子代(24 682例,2.2%)与无PCOS母亲子代(1 073 071例,97.8%)相比,几乎各类儿童期或青春期起病的精神及轻度神经发育障碍风险均升高,且与母亲肥胖、围产期问题、剖宫产和妊娠期糖尿病存在联合效应。

要点

  • 母亲PCOS与子代任何精神科诊断风险升高相关(HR 1.32;95% CI 1.27-1.38)。
  • PCOS与严重肥胖联合时子代任何神经精神障碍风险显著升高(HR 2.11;95% CI 1.76-2.53)。
  • 排除围产期问题后PCOS仍与子代神经精神障碍风险升高相关(HR 1.28;95% CI 1.22-1.34)。

核心结论

  • 母亲PCOS和/或无排卵性不孕独立地、并与母亲肥胖、围产期问题、妊娠期糖尿病和剖宫产联合地,与子代几乎各类儿童期或青春期起病的精神及轻度神经发育障碍风险升高相关。

研究设计与样本

  • 芬兰基于人群的队列研究,纳入1996-2014年间所有活产(n=1 105 997),排除母亲有类似PCOS症状的分娩后余1 097 753例出生(590 939名母亲)。
  • 母亲PCOS子代24 682例(2.2%)与无PCOS母亲子代1 073 071例(97.8%)比较。
  • 使用Cox比例风险模型评估风险比(HR)及95% CI,并调整母亲年龄、出生国、出生时婚姻状况、吸烟、产次、精神疾病、孕期精神药物处方及系统性炎症性疾病等。

主要发现

  • 共105 409例(9.8%)子代被诊断神经发育或精神障碍。
  • 母亲PCOS与子代任何精神科诊断相关(HR 1.32;95% CI 1.27-1.38)。
  • 风险升高见于睡眠障碍(HR 1.46;95% CI 1.27-1.67)、注意缺陷/多动障碍及品行障碍(HR 1.42;95% CI 1.33-1.52)、抽动障碍(HR 1.42;95% CI 1.21-1.68)、智力障碍(HR 1.41;95% CI 1.24-1.60)、孤独症谱系障碍(HR 1.40;95% CI 1.26-1.57)、特定发育障碍(HR 1.37;95% CI 1.30-1.43)、进食障碍(HR 1.36;95% CI 1.15-1.61)、焦虑障碍(HR 1.33;95% CI 1.26-1.41)、心境障碍(HR 1.27;95% CI 1.18-1.35)及其他行为与情绪障碍(ICD-10 F98,HR 1.49;95% CI 1.39-1.59)。
  • 性别间无显著差异;限制于第一胎或母亲无精神科诊断或未购买精神药物的分娩时结果稳健。
  • 按母亲BMI分层:正常体重PCOS母亲子代任何神经精神障碍风险升高(HR 1.20;95% CI 1.09-1.32),严重肥胖PCOS母亲子代风险更高(HR 2.11;95% CI 1.76-2.53),均与正常体重无PCOS母亲子代比较。

临床怎么用

  • 研究提示母亲PCOS和/或无排卵性不孕与子代广泛神经发育不良结局相关,可能有助于妊娠咨询和管理。

局限性

  • 登记-based PCOS患病率低于既往报道,可能捕获的是最严重病例。
  • 将无排卵性不孕与PCOS诊断合并作为PCOS暴露可能引入诊断偏倚。
  • 无法区分PCOS亚型。
  • 家族因素可能混杂母亲PCOS与子代神经精神障碍的关联。
  • 母亲BMI仅2004-2014出生队列可得,且无孕期增重信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is maternal polycystic ovary syndrome (PCOS) associated with increased risks for a broad spectrum of psychiatric and mild neurodevelopmental disorders in offspring? SUMMARY ANSWER: Maternal PCOS and/or anovulatory infertility is independently, and jointly with maternal obesity, perinatal problems, cesarean delivery and gestational diabetes, associated with increased risks in offspring for almost all groups of psychiatric and mild neurodevelopmental disorders with onset in childhood or adolescence. WHAT IS KNOWN ALREADY: Maternal PCOS was previously associated with autism spectrum disorder, attention-deficit/hyperactivity disorders and possibly developmental delay in offspring. Few studies have investigated the association between maternal PCOS and other psychiatric and neurodevelopmental disorders in offspring. STUDY DESIGN, SIZE, DURATION: This was a population-based cohort study in Finland including all live births between 1996 and 2014 (n = 1 105 997). After excluding births to mothers with symptoms similar to PCOS, a total of 1 097 753 births by 590 939 mothers remained. Children were followed up until 31 December 2018, i.e. up to the age of 22 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: National registries were used to link data of the included births and their mothers. Data from 24 682 (2.2%) children born to mothers with PCOS were compared with 1 073 071 (97.8%) children born to mothers without PCOS. Cox proportional hazards modeling was used to evaluate the hazard ratio (HR) and 95% CI for the risk of neuropsychiatric disorders in relation to maternal PCOS. Stratified analyses were performed to test the independent role of PCOS and the joint effects of PCOS with maternal obesity, perinatal problems, cesarean delivery, gestational diabetes and use of fertility treatment. The analysis was adjusted for maternal age, country of birth, marriage status at birth, smoking, parity, psychiatric disorders, prescription of psychotropic N05/N06 during pregnancy and systemic inflammatory diseases when applicable. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 105 409 (9.8%) children were diagnosed with a neurodevelopmental or psychiatric disorder. Firstly, maternal PCOS was associated with any psychiatric diagnosis (HR 1.32; 95% CI 1.27-1.38) in offspring. Particularly, the risk was increased for sleeping disorders (HR 1.46; 95% CI 1.27-1.67), attention-deficit/hyperactivity disorders and conduct disorders (HR 1.42; 95% CI 1.33-1.52), tic disorders (HR 1.42; 95% CI 1.21-1.68), intellectual disabilities (HR 1.41; 95% CI 1.24-1.60), autism spectrum disorder (HR 1.40; 95% CI 1.26-1.57), specific developmental disorders (HR 1.37; 95% CI 1.30-1.43), eating disorders (HR 1.36; 95% CI 1.15-1.61), anxiety disorders (HR 1.33; 95% CI 1.26-1.41), mood disorders (HR 1.27; 95% CI 1.18-1.35) and other behavioral and emotional disorders (ICD-10 F98, HR 1.49; 95% CI 1.39-1.59). In short, there was no significant difference between sexes. The results were robust when restricting the analyses to the first-born children or births to mothers without psychiatric diagnosis or purchase of psychotropic medication. Secondly, stratified analysis according to maternal BMI showed that the risk of any neuropsychiatric disorder was increased in offspring to normal-weight mothers with PCOS (HR 1.20; 95% CI 1.09-1.32), and markedly higher in those to severely obese mothers with PCOS (HR 2.11; 95% CI 1.76-2.53) compared to offspring to normal-weight mothers without PCOS. When excluding perinatal problems, mothers with PCOS were still associated with increased risks of any neuropsychiatric disorders in offspring (HR 1.28; 95% CI 1.22-1.34) compared to mothers without PCOS. However, an additional increase was observed for PCOS in combination with perinatal problems (HR 1.99; 95% CI 1.84-2.16). Likewise, excluding cases with maternal gestational diabetes (HR 1.30; 95% CI 1.25-1.36), cesarean delivery (HR 1.29; 95% CI 1.23-1.35) or fertility treatment (HR 1.31; 95% CI 1.25-1.36) did not eliminate the associations. LIMITATIONS, REASONS FOR CAUTION: The register-based prevalence of PCOS was lower than previously reported, suggesting that this study may capture the most severe cases. To combine anovulatory infertility with PCOS diagnosis as PCOS exposure might introduce diagnostic bias. It was not feasible to distinguish between subtypes of PCOS. Furthermore, familial factors might confound the association between maternal PCOS and neuropsychiatric disorders in offspring. Maternal BMI was available for birth cohort 2004-2014 only and there was no information on gestational weight gain. WIDER IMPLICATIONS OF THE FINDINGS: This study provides further evidence that maternal PCOS and/or anovulatory infertility, independently and jointly with maternal obesity, perinatal problems, gestational diabetes and cesarean delivery, implies a broad range of adverse effects on offspring neurodevelopment. These findings may potentially help in counseling and managing pregnancies. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the joint research funding of Shandong University and Karolinska Institute (SDU-KI-2019-08 to X.C and C.L.), THL Finnish Institute for Health and Welfare: Drug and pregnancy project [M.G.], the Swedish Research Council [2014-10171 to C.L.], the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institute Stockholm County Council [SLL20170292 to C.L.], the Swedish Brain Foundation [FO2018-0141 and FO2019-0201 to C.L.]. X.C. was supported by the China Scholarship Council during her training in Karolinska Institute. L.K. was supported by the China Scholarship Council for his PhD study in Karolinska Institute. The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Chen X, Kong L, Piltonen TT, et al. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study. Hum Reprod. 2020. PMID: 32866965. doi:10.1093/humrep/deaa192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。